Atlas Trials

Marina N Sharifi

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Marina N Sharifi

RecordFirmDate
Alpelisib (BYL719) in Combination With Continued Endocrine Therapy Following Progression on Endocrine Therapy in Hormone Receptor Positive, HER2 Negative, PIK3CA Mutant Metastatic Breast Cancer (NCT04762979)Marina N Sharifi2021-02-12

Track Marina N Sharifi automatically

Every clearance here is in the API, with alerts when new ones post.